🔎 Trials Near Me

Home › Kanser ng Endometrium › Oregon › Eugene

Pag-aaral pangklinika para sa Kanser ng Endometrium sa Eugene, OR

Isang pag-aaral para sa Kanser ng Endometrium ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Eugene. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

Nagre-recruitPhase 3
  • Willamette Valley Cancer Institute and Research Center - Eugene, Eugene
Edad 18 pataas · Kababaihan · Na-update Set 9, 2026 · NCT07166094

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Nagre-recruitPhase 1/2
  • USOR Oncology Associates of Oregon, P.C., Eugene
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT05579366

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Nagre-recruitPhase 3
  • Research Site, Eugene
Edad 18 pataas · Kababaihan · Na-update Hul 29, 2026 · NCT07044336

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Nagre-recruitPhase 2
  • 517, Eugene
Edad 18 pataas · Kababaihan · Na-update Hul 16, 2026 · NCT06906341

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

Nagre-recruitPhase 2
  • Oncology Associates of Oregon, P.C., Eugene
Edad 18 pataas · Kababaihan · Na-update Dis 24, 2025 · NCT06463028

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

Nagre-recruitPhase 2/3
  • Oncology Associates of Oregon, Eugene
Edad 18 pataas · Kababaihan · Na-update May 2, 2024 · NCT05797831

Pag-aaral para sa Kanser ng Endometrium sa ibang lungsod

Iba pang pag-aaral sa Eugene

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.